KRRO - Korro Bio, Inc.
NEXT EARNINGS:
Mar 17, 2026
(in 20 days)
EPS Est: $-1.93
|
Rev Est: $425000
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$19.43
DETAILS
HIGH:
$30.00
LOW:
$10.00
MEDIAN:
$20.00
CONSENSUS:
$19.43
UPSIDE:
62.87%
Market Cap:
112.35M
Volume:
254,907
Avg Volume:
286,098
52 Week Range:
5.204-55.89
Sector:
Healthcare
Industry:
Biotechnology
Beta:
2.44
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
112
IPO Date:
2019-10-03
EPS (TTM):
-9.37
P/E Ratio:
-4.06
Revenue (TTM):
2.27M
Total Assets:
226.24M
Total Debt:
44.77M
Cash & Equiv:
55.64M
Rev Growth (5Y):
-39.9%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-43.5%
Debt/Equity:
0.28
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-12 | $-1.92 | $-2.61 | +26.4% | $1.1M | $425000 | +156.5% |
| 2025-08-12 | $-2.74 | $-2.54 | -7.9% | $1.5M | $320780 | +355.1% |
| 2025-05-07 | $-2.49 | $-2.60 | +4.2% | $2.5M | $426900 | +497.3% |
| 2025-03-18 | $-2.26 | $-2.33 | +3.0% | $2.3M | — | — |
| 2024-11-12 | $-2.26 | $-2.55 | +11.4% | — | — | — |
| 2024-08-13 | $-2.43 | $-2.40 | -1.3% | — | — | — |
| 2024-05-14 | $-2.44 | $-2.36 | -3.4% | — | — | — |
| 2024-03-29 | $-25.65 | $-2.36 | -986.9% | — | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.27M | 0 | 0 | 14.07M | 36.98M | 28.95M | 0 | 0 |
| Net Income | (83.58M) | (81.17M) | (58.03M) | (84.69M) | (26.51M) | (18.75M) | (19.17M) | (20.24M) |
| EPS | -9.37 | -53.09 | -227.58 | -4.94 | -41.10 | -30.39 | -30.57 | -32.27 |
| Total Assets | 226.24M | 221.66M | 73.74M | 185.36M | 264.72M | 223.22M | 44.55M | 19.79M |
| Total Debt | 44.77M | 33.21M | 166.99M | 45.60M | 45.99M | 0 | 84.94M | 46.69M |
| Cash & Equivalents | 55.64M | 166.15M | 36.94M | 79.64M | 220.34M | 200.16M | 42.19M | 17.94M |
| Operating Cash Flow | (60.07M) | (67.28M) | (53.65M) | (32.09M) | (45.19M) | 34.22M | (17.02M) | (14.61M) |
| Free Cash Flow | (77.98M) | (75.12M) | (58.86M) | (36.54M) | (51.86M) | 33.15M | (17.46M) | (16.48M) |
| FCF per Share | -8.74 | -49.13 | -230.81 | -8.22 | -80.39 | 53.74 | -27.84 | -26.28 |
| Book Value | 160.41M | 169.91M | (99.03M) | 130.82M | 192.49M | 167.36M | (48.28M) | (29.64M) |
| Cash & ST Investments | 126.09M | 166.15M | 55.85M | 130.71M | 220.34M | 217.35M | 42.19M | 17.94M |
| ROC Equity | -0.52 | -0.48 | N/A | -0.65 | -0.14 | -0.11 | N/A | N/A |